BREAKING NEWS. BMJ COMMENTA LA NUOVA COMMISSIONE ITALIANA VACCINI !

GASTROENTEROLOGIA, MEDICINA INTERNA, NEWSLETTER

Vaccine sceptics appointed to advise Italian government on immunisation Italy’s health minister has appointed two doctors with anti-vaccine views as advisers on immunisation policy, sending shockwaves through the country’s scientific community. The minister of health, Orazio Schillaci, formally reinstituted the National Immunisation Technical Advisory Group (NITAG) and appointed its members on 5 August.1 The most contentious…

SIETE STRESSATI? PRENDETE UN PROBIOTICO! UN TRIAL SULLO STRESS ACCADEMICO E Lacticaseibacillus rhamnosus. FINALMENTE UN ALTRO TRIAL BEN FATTO SUI PROBIOTICI. DA “nature npj biofilms and microbiomes” (FREE!)

GASTROENTEROLOGIA, IBS, MEDICI DI FAMIGLIA, MEDICINA DEI PROBIOTICI, NEWSLETTER

Probiotic-mediated modulation of gut microbiome in students exposed to academic stress: a randomized controlled trial Jorge Francisco Vázquez-Castellanos et al. Abstract Probiotics have been widely tested for their effect on mental well-being, albeit with heterogeneous outcomes. Direct and indirect effects through the gut microbiome might lie at the basis of these observations. Here, in a…

RIFAXIMINA NEL CIRROTICO. UN TRIAL SU 159 ASCITICI. RIFAXIMINA NON MIGLIORA SOPRAVVIVENZA E COMPLICAZIONI. O NO? OCCHIO ALLA ADERENZA ALLA TERAPIA. DA “J. OF HEPATOLOGY” (FREE!)

EPATOLOGIA, EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, NEWSLETTER

Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled clinical trial Thierry Thévenot et al. Highlights Standard of care for primary prophylaxis of spontaneous bacterial peritonitis currently relies on norfloxacin. 159 cirrhotic patients with ascites were enrolled in a double-blind, randomized trial. Participants received rifaximin or placebo for 12 months. Rifaximin…

LEGATURA VARICI: NON USATE DOPO GLI INIBITORI DELLA POMPA PROTONICA! UN OTTIMO TRIAL SEGNALA UN ECCESSO DI SIDE EFFECTS. DA “DIAGNOSTICS” (FREE!)

CIRROSI EPATICA, ENDOSCOPIA, EPATOLOGIA, GASTROENTEROLOGIA, NEWSLETTER

Proton Pump Inhibitor Use Following Esophageal Variceal Ligation and Its Impact on Clinical Outcomes: Real-World Data from the TriNetX Global Collaborative Network Nisar Amin et al. Abstract Background: Proton pump inhibitors (PPIs) are frequently used after endoscopic variceal ligation (EVL) to reduce post-procedural bleeding, though studies have shown mixed results regarding their efficacy. While some suggest…